Delivery Order SPE2DB24D2003-SPE2DB25FXKM0
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,027.44 for Fycompa 8 mg tablets (30-count) with an ultimate completion date of September 5, 2025. This competitive delivery order, issued under firm fixed-price terms with no set-aside designation, represents a single pharmaceutical supply transaction fulfilled from the contractor's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 14, 2025, valued at $1,489.87 for the supply of Fycompa 2 mg tablets (30-count packages) under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order issued by the Defense Logistics Agency's Medical Supply Chain, a component of the Department of Defense. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $1,580.41 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fycompa 8 mg tablets (30-count packages). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's place of performance. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,524.73 to AmerisourceBergen Drug Corp for the supply of Fycompa 4 mg tablets (30-count units). This firm fixed-price, competitively awarded contract was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition for this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,072.56 to AmerisourceBergen Drug Corp for 30 tablets of Fycompa 6 mg on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Fycompa is an antiepileptic medication used to treat partial-onset seizures, reflecting AmerisourceBergen's role...
- The Defense Logistics Agency awarded a $2,067.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 4 MG tablets (30-count packaging) on July 10, 2025, with completion expected by July 11, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,148.08 by the Defense Logistics Agency on August 5, 2025, for the supply of Fycompa 4 mg tablets (30-count). This firm fixed-price delivery order, which concludes on August 6, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fycompa 8 mg tablets (30-count) with a ceiling value of $1,417.05. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of FYCOMPA 4 mg tablets (30-count units) with a ceiling value of $3,134.37. This firm fixed-price delivery order, which has an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $7,307.89 to AmerisourceBergen Drug Corp for Fycompa 0.5 mg/ml oral suspension (340ml) on July 18, 2025. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, with performance to occur at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXKM0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,111.20 to AmerisourceBergen Drug Corp for the supply of Fycompa 4 mg tablets (30-count units) on July 10, 2025, with completion scheduled for July 11, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and was performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfilled this order as a child contract under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. This delivery order exemplifies the scope of AmerisourceBergen's federal pharmaceutical supply role, which extends across the Defense Health Agency, military healthcare systems, and other government healthcare providers. Fycompa is a neurological medication, consistent with the contractor's extensive portfolio of specialty medications and brand-name drugs supplied through the DLA Troop Support Medical prime vendor contract. The DLA's pharmaceutical procurement strategy leverages AmerisourceBergen's capabilities through flexible delivery order mechanisms that enable rapid fulfillment of varied medical supply needs across military and federal healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/10/25 |